...plus tiered royalties. Also in April, Fate Therapeutics Inc. acquired Verio Therapeutics Inc. for an undisclosed sum. Verio's...
...discussing the specifics of the preclinical stem cell modulators it gained through the acquisition of Verio...
...Co. (NYSE:PG), Cincinnati, Ohio sanofi-aventis Group (Euronext:SAN; NYSE:SNY), Paris, France Tolerx Inc. , Cambridge, Mass. Verio Therapeutics Inc....

...Fate said Verio's biologics capabilities and preclinical programs complement its pipeline of stem cell modulators. Verio's...
...in patients with hematologic malignancies undergoing non-myeloablative therapy. Fate Therapeutics Inc. , San Diego, Calif. Verio Therapeutics Inc....

...Fate said Verio's biologics capabilities and preclinical programs complement its pipeline of stem cell modulators. Verio's...